Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Aravive Inc.
Headquarters: Houston, TX, United States of America
Website: http://aravive.com/
Year Founded: 2008
Status: Private
BioCentury | Apr 24, 2024
Management Tracks
Evotec names Christian Wojczewski CEO
Plus: Novartis proposes Giovanni Caforio as chair and updates from Congruence, Recludix, Calluna and more
BioCentury | Aug 3, 2023
Finance
Aug. 3 Quick Takes: Kyverna extends B round to $145M
Plus: Aravive low on cash after ovarian cancer miss, Agios to develop Alnylam program, and updates from Seagen and Amber
BioCentury | Apr 11, 2023
Management Tracks
Legend hires Koneru as CMO
Plus: Erasca promotes Morris, Lovejoy and updates from Poseida, Mithra, Tune, Cellarity and more
BioCentury | Apr 20, 2022
Data Byte
The Phase III pipeline for ovarian cancer
Companies are testing 15 therapies across four mechanisms; five trials to report data this year
BioCentury | Mar 30, 2022
Emerging Company Profile
SalioGen: genome editing without viruses or nucleases
The Cambridge, Mass.-based biotech is using mammalian enzymes to insert DNA into the genome without causing breaks
BioCentury | Mar 29, 2022
Management Tracks
Rangwala to be CMO at Karyopharm
Plus Jones becomes CFO at Sense, and updates from Enzo, Dice and more
BioCentury | May 1, 2020
Product Development
April 30 Quick Takes: Pfizer to co-develop Valneva’s Lyme disease vaccine; plus Aravive-WuXi Biologics, Siga-BARDA, Pear, Capricor
BioCentury | Jan 11, 2020
Company News
Management Tracks: Wave CFO departs; plus Polaris, Turning Point, ADC, Relmada, Aravive, Affimed, Impel, Candel and more
BioCentury | Nov 27, 2019
Company News
Nov. 27 Company Quick Takes: Orexo, GAIA in second deal for substance abuse digital therapy; plus PDUFA date for Verrica's skin infection candidate and $25M fol
Items per page:
1 - 10 of 10